ORIC Pharmaceuticals, Inc. (ORIC) Misses Q2 EPS by 4c

ORIC Pharmaceuticals, Inc. (NASDAQ: ORIC) reported Q2 EPS of ($0.45), $0.04 worse than the analyst estimate of ($0.41).

For earnings history and earnings-related data on ORIC Pharmaceuticals, Inc. (ORIC) click here.

You May Also Be Interested In

• BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
• Canadian trade officials to meet U.S. counterparts in Washington Monday
• Mark Walter, Todd Boehly in talks to sell Chelsea stakes - FT